Literature DB >> 10717750

Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren.

J A Kurtzhals1, M M Addae, B D Akanmori, S Dunyo, K A Koram, M A Appawu, F K Nkrumah, L Hviid.   

Abstract

A cohort of 250 Ghanaian schoolchildren aged 5-15 years was followed clinically and parasitologically for 4 months in 1997/98 in order to study the effect of asymptomatic Plasmodium falciparum infections on haematological indices and bone-marrow responses. Of the 250 children 65 met the predefined study criteria. Thus, 14 children were parasite-free throughout (group 1), 44 had P. falciparum in all blood samples collected but no symptoms of malaria (group 2), and 7 had 1 malaria attack during the study period (group 3). At the end of the study the mean haemoglobin (Hb) level in group 1 was 123 g/L, significantly higher than the value of 114 g/L in groups 2 and 3 (P < 0.02, adjusted for age and splenomegaly). The low Hb in group 2 was associated with subnormal plasma iron. Low Hb was associated with elevated erythropoietin (EPO) levels, and there was a positive correlation between EPO and reticulocyte counts. However, the reticulocyte response to EPO was more pronounced in uninfected than in infected children, suggesting a partial interference with erythropoiesis in asymptomatic infections. Children with asymptomatic infections had significantly higher plasma levels of tumour necrosis factor than uninfected children (geometric means 50 ng/L and 27 ng/L, respectively, P < 0.001) and this cytokine may contribute to bone-marrow suppression and disturbed iron metabolism. We suggest that asymptomatic malaria leads to a homeostatic imbalance in which erythrocyte loss due to parasite replication is only partially compensated for by increased erythropoiesis. The consequences of the reduced Hb levels on the development and cognitive abilities of children with asymptomatic infections, and the risk of precipitation of iron deficiency, deserve further study and should be considered in malaria control programmes that aim at reducing morbidity rather than transmission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10717750     DOI: 10.1016/s0035-9203(99)90073-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  30 in total

Review 1.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria.

Authors:  V Nussenblatt; G Mukasa; A Metzger; G Ndeezi; E Garrett; R D Semba
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.

Authors:  Steven E Kern; Alfred B Tiono; Michael Makanga; Adama Dodji Gbadoé; Zulfiqarali Premji; Oumar Gaye; Issaka Sagara; David Ubben; Marc Cousin; Fiyinfolu Oladiran; Oliver Sander; Bernhards Ogutu
Journal:  Malar J       Date:  2011-07-29       Impact factor: 2.979

4.  Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Authors:  Chandy C John; Ann M Moormann; Peter O Sumba; Ayub V Ofulla; Daniel C Pregibon; James W Kazura
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 5.  Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review.

Authors:  Jennifer L Smith; Simon Brooker
Journal:  Trop Med Int Health       Date:  2010-05-25       Impact factor: 2.622

6.  Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.

Authors:  Breanna Barger; Hamma Maiga; Oumar Bila Traore; Mamadou Tekete; Intimbeye Tembine; Antoine Dara; Zoumana Isaac Traore; Soren Gantt; Ogobara K Doumbo; Abdoulaye A Djimde
Journal:  Trop Med Int Health       Date:  2009-05-26       Impact factor: 2.622

Review 7.  Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.

Authors:  Simon Brooker; Willis Akhwale; Rachel Pullan; Benson Estambale; Siân E Clarke; Robert W Snow; Peter J Hotez
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

Authors:  Bernhards Ogutu; Alfred B Tiono; Michael Makanga; Zulfiqarali Premji; Adama Dodji Gbadoé; David Ubben; Anne Claire Marrast; Oumar Gaye
Journal:  Malar J       Date:  2010-01-22       Impact factor: 2.979

Review 9.  The health impact of polyparasitism in humans: are we under-estimating the burden of parasitic diseases?

Authors:  R Pullan; S Brooker
Journal:  Parasitology       Date:  2008-03-27       Impact factor: 3.234

10.  Impact of Plasmodium falciparum infection on the frequency of moderate to severe anaemia in children below 10 years of age in Gabon.

Authors:  Marielle K Bouyou-Akotet; Arnaud Dzeing-Ella; Eric Kendjo; Diane Etoughe; Edgard B Ngoungou; Timothy Planche; Jean Koko; Maryvonne Kombila
Journal:  Malar J       Date:  2009-07-20       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.